Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells

S Alivernini, B Tolusso, G Ferraccioli, E Gremese, M Kurowska-Stolarska, I B McInnes

Research output: Contribution to journalReview article

Abstract

Acute inflammation is a complex and tightly regulated homeostatic process that includes leucocyte migration from the vasculature into tissues to eliminate the pathogen/injury, followed by a pro-resolving response promoting tissue repair. However, if inflammation is uncontrolled as in chronic diseases such as rheumatoid arthritis (RA), it leads to tissue damage and disability. Synovial tissue inflammation in RA patients is maintained by sustained activation of multiple inflammatory positive-feedback regulatory pathways in a variety of cells, including myeloid cells. In this review, we will highlight recent evidence uncovering biological mechanisms contributing to the aberrant activation of myeloid cells that contributes to perpetuation of inflammation in RA, and discuss emerging data on anti-inflammatory mediators contributing to sustained remission that may inform a novel category of therapeutic targets.

Original languageEnglish
Pages (from-to)13-23
Number of pages11
JournalClinical and Experimental Immunology
Volume193
Issue number1
DOIs
Publication statusPublished - Jul 2018

Fingerprint Dive into the research topics of 'Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells'. Together they form a unique fingerprint.

  • Cite this

    Alivernini, S., Tolusso, B., Ferraccioli, G., Gremese, E., Kurowska-Stolarska, M., & McInnes, I. B. (2018). Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells. Clinical and Experimental Immunology, 193(1), 13-23. https://doi.org/10.1111/cei.13098